Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Minority Interest (2020 - 2022)

Cullinan Therapeutics (CGEM) has 3 years of Minority Interest data on record, last reported at $80000.0 in Q2 2022.

  • For Q2 2022, Minority Interest fell 97.33% year-over-year to $80000.0; the TTM value through Jun 2022 reached $80000.0, down 97.33%, while the annual FY2021 figure was $403000.0, 69.1% down from the prior year.
  • Minority Interest reached $80000.0 in Q2 2022 per CGEM's latest filing, down from $768000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $3.0 million in Q2 2021 and bottomed at $80000.0 in Q2 2022.
  • Average Minority Interest over 3 years is $1.5 million, with a median of $1.3 million recorded in 2020.
  • Peak YoY movement for Minority Interest: skyrocketed 135.7% in 2021, then tumbled 97.33% in 2022.
  • A 3-year view of Minority Interest shows it stood at $1.3 million in 2020, then tumbled by 69.1% to $403000.0 in 2021, then plummeted by 80.15% to $80000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Minority Interest were $80000.0 in Q2 2022, $768000.0 in Q1 2022, and $403000.0 in Q4 2021.